Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes

McGuire, Darren K.; Marx, Nikolaus; Mulvagh, Sharon L.; Deanfield, John E.; Inzucchi, Silvio E.; Pop-Busui, Rodica; Mann, Johannes F.E.; Emerson, Scott S.; Poulter, Neil R.; Engelmann, Mads D.M.; Ripa, Maria Sejersten; Hovingh, G. Kees; Brown-Frandsen, Kirstine; Bain, Steve; Cavender, Matthew A.; Gislum, Mette; David, Jens-Peter; Buse, John B.

doi:10.1056/nejmoa2501006

Journal article 111 views 22 downloads

Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes

Darren K. McGuire, Nikolaus Marx, Sharon L. Mulvagh, John E. Deanfield, Silvio E. Inzucchi, Rodica Pop-Busui, Johannes F.E. Mann, Scott S. Emerson, Neil R. Poulter, Mads D.M. Engelmann, Maria Sejersten Ripa, G. Kees Hovingh, Kirstine Brown-Frandsen, Steve Bain

, Matthew A. Cavender

, Mette Gislum, Jens-Peter David, John B. Buse

New England Journal of Medicine

Swansea University Author: Steve Bain

PDF | Accepted Manuscript

Released under the terms of a Creative Commons Attribution–NonCommercial–No Derivatives International license (CC BY-NC-ND).
Download (283.66KB)

Check full text

DOI (Published version): 10.1056/nejmoa2501006

Published in:	New England Journal of Medicine
ISSN:	0028-4793 1533-4406
Published:	Massachusetts Medical Society 2025
Online Access:	Check full text
URI:	https://cronfa.swan.ac.uk/Record/cronfa69194

Description
Staff View

College:	Faculty of Medicine, Health and Life Sciences

Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes

Similar Items